Cagrilintide 10
Mechanism of action: It mimics endogenous amylin, suppressing appetite, delaying gastric emptying, and reducing food intake; it can also act synergistically with GLP-1 receptor agonists to enhance weight loss effects.
Hover to zoom
Cagrilintide 10
Mechanism of action: It mimics endogenous amylin, suppressing appetite, delaying gastric emptying, and reducing food intake; it can also act synergistically with GLP-1 receptor agonists to enhance weight loss effects.
Product details
Cagrilintide is a long-acting amylin analog peptide drug primarily used to treat obesity and overweight.
Mechanism of action: It mimics endogenous amylin, suppressing appetite, delaying gastric emptying, and reducing food intake; it can also act synergistically with GLP-1 receptor agonists to enhance weight loss effects.
Our products are provided in a freeze-dried, lyophilized powder that is vacuum sealed in a sterile vial format that typically require reconstitution with an applicable solvent or solution and intended for research use only.
Our products are provided in a freeze-dried, lyophilized powder that is vacuum sealed in a sterile vial format that typically require reconstitution with an applicable solvent or solution and intended for research use only.
